Starting with Exelixis’ condition on in-house dispensing data, manufacturers are introducing a new approach to 340B claims focused on transparency.
News|Articles|March 27, 2008
CIGNA offers generic coupons, price comparisons on its online Rx price quote tool
CIGNA adds online generic coupons and prescription drug price comparisons to its online prescription drug price quote tool
Advertisement
To see more Daily News articles,
To go to the Drug Topics homepage,
Advertisement
Related to this article
A high-dose flu vaccine lowered flu- and pneumonia-related hospital stays in patients with chronic lung disease, reinforcing flu and pneumococcal vaccinations.
In a review of records assessing patients with type 2 diabetes, researchers provide a comprehensive detail of strategies leading to diabetes remission though gaps persist.
A guide built from conversations with pharmacists on social media and independent pharmacy owners.
Exploring the effects of weight-loss and GLP-1 therapies, researchers determine the specific metabolic determinants that lead to patients’ weight reduction.
Observed by APhA and ASHP since 2023, bipartisan support has garnered to give pharmacy workforce suicide awareness its own federally recognized day.
Atogepant reduced migraine days during the perimenstrual period, positioning the medication as a potential first treatment option for the condition.
Chad Worz, PharmD, BCGP, FASCP, discusses the Main Street Pharmacy Access Act, a revolutionary pharmacy-focused bill moving through Congress.
Advertisement
Advertisement
Trending on Drug Topics
1
Johnson & Johnson Next Major Drugmaker to Require 340B Claims Data
2
COVID-19 Vaccine Hesitancy in 2026: How Attitudes Have Shifted
3
Generic Drug Costs Burdening Patients as Much as Brand Name Options
4
Social Media Best Practices for Pharmacists: Why Visibility Matters
5